SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-12-006092
Filing Date
2012-11-14
Accepted
2012-11-14 08:00:38
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0912_soligenix.htm 10-Q 661117
2 CERTIFICATION f10q0912ex31i_soligenix.htm EX-31.1 14138
3 CERTIFICATION f10q0912ex31ii_soligenix.htm EX-31.2 13834
4 CERTIFICATION f10q0912ex32i_soligenix.htm EX-32.1 5883
5 CERTIFICATION f10q0912ex32ii_soligenix.htm EX-32.2 5909
  Complete submission text file 0001213900-12-006092.txt   3688630

Data Files

Seq Description Document Type Size
6 sngx-20120930.xml EX-101.INS 521109
7 sngx-20120930.xsd EX-101.SCH 24334
8 sngx-20120930_cal.xml EX-101.CAL 30674
9 sngx-20120930_def.xml EX-101.DEF 87825
10 sngx-20120930_lab.xml EX-101.LAB 232266
11 sngx-20120930_pre.xml EX-101.PRE 157529
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 121201027
SIC: 2834 Pharmaceutical Preparations